Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 1.4x - 1.6x | 1.5x |
| Historical Pb Multiple | 1.3x - 2.4x | 1.5x |
| Fair Value | ₩6,268 - ₩6,928 | ₩6,598 |
| Upside | 3.4% - 14.3% | 8.9% |
| Benchmarks | - | Full Ticker |
| BCWORLD PHARM. Co., Ltd. | - | KOSDAQ:A200780 |
| Ahn-Gook Pharmaceutical Co., Ltd. | - | KOSDAQ:A001540 |
| Kyung Dong Pharmaceutical Co., Ltd. | - | KOSDAQ:A011040 |
| Sam-A Pharm. Co., Ltd | - | KOSDAQ:A009300 |
| JW Lifescience Corporation | - | KOSE:A234080 |
| Sinsin Pharmaceutical Co., Ltd | - | KOSDAQ:A002800 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| A200780 | A001540 | A011040 | A009300 | A234080 | A002800 | |||
| KOSDAQ:A200780 | KOSDAQ:A001540 | KOSDAQ:A011040 | KOSDAQ:A009300 | KOSE:A234080 | KOSDAQ:A002800 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | 46.0% | -22.9% | 16.7% | 14.9% | 18.0% | ||
| 3Y CAGR | NM- | 62.3% | -24.4% | 86.7% | 50.5% | NM- | ||
| Latest Twelve Months | -674.5% | 1205.7% | 126.4% | -20.6% | 56.3% | 28.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -3.2% | 2.2% | 3.3% | 13.2% | 10.4% | 2.4% | ||
| Prior Fiscal Year | 3.5% | 0.6% | -12.7% | 22.0% | 13.6% | 4.6% | ||
| Latest Fiscal Year | -5.9% | 6.2% | 2.8% | 23.1% | 19.8% | 4.6% | ||
| Latest Twelve Months | -5.9% | 6.2% | 2.8% | 23.1% | 19.8% | 4.6% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -1.7% | 3.4% | 2.3% | 6.2% | 14.5% | 4.0% | ||
| Prior Fiscal Year | 7.5% | 0.8% | -8.5% | 11.2% | 18.8% | 7.7% | ||
| Latest Twelve Months | -5.6% | 10.6% | 2.4% | 8.9% | 24.4% | 8.6% | ||
| Next Fiscal Year | -11.5% | 22.5% | 1.0% | 9.2% | 26.0% | 7.0% | ||
| Two Fiscal Years Forward | -13.1% | 23.1% | 3.5% | 8.6% | 22.0% | 6.8% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.6x | 0.3x | 0.8x | 1.1x | 0.8x | 0.9x | ||
| Price / LTM EPS | -9.6x | 5.0x | 29.2x | 5.4x | 4.2x | 16.6x | ||
| Price / Book | 0.6x | 0.5x | 0.7x | 0.5x | 0.9x | 1.4x | ||
| Price / Fwd Book | 0.6x | 0.4x | 0.8x | 0.4x | 0.7x | 1.3x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.5x | 0.6x | 0.9x | |||||
| Historical P/B Ratio | 1.3x | 1.5x | 2.4x | |||||
| Selected P/B Multiple | 1.4x | 1.5x | 1.6x | |||||
| (x) Book Value | 66,596 | 66,596 | 66,596 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A200780 | A001540 | A011040 | A009300 | A234080 | A002800 | |
| Value of Common Equity | 42,721 | 84,104 | 159,765 | 102,902 | 185,505 | 91,933 | |
| (/) Shares Outstanding | 9.2 | 11.4 | 26.9 | 6.1 | 15.5 | 15.2 | |
| Implied Stock Price | 4,625.00 | 7,400.00 | 5,930.00 | 16,860.00 | 11,980.00 | 6,060.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4,625.00 | 7,400.00 | 5,930.00 | 16,860.00 | 11,980.00 | 6,060.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
The video below provides an overview of the key benefits to help you get the most out of InvestingPro.